BMEA - What's Going On With Biomea Fusion Stock? | Benzinga
Biomea Fusion, Inc. (NASDAQ: BMEA) shares are trading lower Monday. The stock appears to be moving on continued downward momentum and has lost nearly 40% in the past five days.
What To Know:
Biomea Fusion announced on Monday that it presented clinical data for BMF-219, an investigational covalent menin inhibitor, in relapsed / refractory AML patients with menin-dependent mutations at the 65th American Society of Hematology Annual Meeting.
On Saturday, ...